
MergerNov 9, 2026, 04:17 PM
Surgery Partners Amends Merger Deal to $6B; Q3 Revenue Down 0.8%
AI Summary
Surgery Partners, Inc. announced an amendment to its merger agreement with HealthSpan Partners, increasing the per-share cash consideration to $25.00, reflecting an enterprise value of up to $6.0 billion. This amendment follows the receipt of a competing proposal. The company also reported its third-quarter results, with revenue decreasing 0.8% to $815.3 million, while same-facility revenues increased 6.0%. The net loss attributable to Surgery Partners was $21.1 million. Due to the pending merger, the company will not host an earnings call or provide future guidance.
Key Highlights
- Surgery Partners amended merger agreement with HealthSpan Partners, increasing consideration to $25.00 per share cash.
- The amended deal values the company at up to approximately $6.0 billion enterprise value.
- Third quarter revenue decreased 0.8% to $815.3 million; same-facility revenues increased 6.0%.
- Net loss attributable to Surgery Partners was $21.1 million for Q3 2026.
- Adjusted EBITDA for Q3 2026 was $132.7 million, down from $136.4 million in Q3 2025.
- Company will not host an earnings call or provide forward-looking guidance due to the pending transaction.
Price Impact
More from SGRY